Abstract
A study was carried out on 11 169 matched case-control pairs of children aged up to 15 years included in the Oxford Survey of Childhood Cancers to see whether an association exists between cancer in children and drugs given to their mothers during pregnancy. The mothers of children who developed cancer reported about 25% more illnesses during pregnancy than mothers of healthy control children. Two specific illnesses, pulmonary tuberculosis and epilepsy, were investigated. For these there was a higher than average case-control excess of reports and there had been a suggestion that the drugs used in treatment, isoniazid and phenytoin, might be carcinogenic. The results of this investigation provide no real evidence for any association between the drugs taken by the mothers during pregnancy and subsequent cancer in the child.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gold E., Gordis L., Tonascia J., Szklo M. Increased risk of brain tumors in children exposed to barbiturates. J Natl Cancer Inst. 1978 Oct;61(4):1031–1034. [PubMed] [Google Scholar]
- Herbst A. L., Ulfelder H., Poskanzer D. C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 Apr 15;284(15):878–881. doi: 10.1056/NEJM197104222841604. [DOI] [PubMed] [Google Scholar]
- Li F. P., Willard D. R., Goodman R., Vawter G. Malignant lymphoma after diphenylhydantoin (dilantin) therapy. Cancer. 1975 Oct;36(4):1359–1362. doi: 10.1002/1097-0142(197510)36:4<1359::aid-cncr2820360426>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- Pendergrass T. W. Letter: Fetal hydantoin syndrome and neuroblastoma. Lancet. 1976 Jul 17;2(7977):150–150. doi: 10.1016/s0140-6736(76)92882-8. [DOI] [PubMed] [Google Scholar]
- Sherman S., Roizen N. Fetal hydantoin syndrome and neuroblastoma. Lancet. 1976 Sep 4;1(7984):517–517. doi: 10.1016/s0140-6736(76)90808-4. [DOI] [PubMed] [Google Scholar]